Symic Biomedical
San Francisco, US · Founded 2012 · 4 known investors
Biotech
Founders & leadership
KN
KENNETH N. HORNENamed on SEC filing
KS
KATE STUARTNamed on SEC filing
AP
ALYSSA PANITCHNamed on SEC filing
JP
JOHN PADERINamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2013
▶$1.4MraisedJan 2014 · 16 investors · BiotechnologyRule 506(b)
▶$1.4MraisedJan 2014 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KENNETH N. HORNEExecutive Officer, Director
- KATE STUARTExecutive Officer
- ALYSSA PANITCHDirector
- JOHN PADERIDirector
- Offering amount
- $1.5M
- Amount sold
- $1.4M
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Symic Biomedical's investors?
- Symic Biomedical's investors include Mitsui Global Investment, Ally Bridge Group, InCube Ventures, Lilly Ventures.
- How much funding has Symic Biomedical raised?
- Symic Biomedical has disclosed $1.4M raised across 1 round.
- Where is Symic Biomedical headquartered?
- Symic Biomedical is headquartered in San Francisco, US.